+254745601747

info@clinicalmedhub.com

Nairobi, Kenya

Spironolactone - Drug Details

Spironolactone (Aldactone)

Classification
Potassium-sparing diuretic, aldosterone antagonist
Mechanism of Action
Indications
Heart failure, hypertension, hyperaldosteronism
Dosage and Administration
25-100 mg orally once daily
Forms
Tablets
Side Effects
Hyperkalemia, gynecomastia, menstrual irregularities
Contraindications
Hyperkalemia, Addison's disease
Interactions
May increase serum potassium with ACE inhibitors
Precautions
Monitor electrolytes regularly, use caution in renal impairment
Pharmacokinetics
Half-life: 1.4 hours, active metabolites have longer half-lives
Pharmacodynamics
Inhibits the effects of aldosterone on the distal tubules
Storage Requirements
Store at room temperature, protect from light and moisture
Patient Counselling
Monitor blood pressure and potassium levels regularly
Back to List
ClinicalMedHub - Modern Footer

ClinicalMedHub

Comprehensive medical resources, research tools, and professional networking for healthcare providers and patients worldwide.

Scroll down to see the modern footer design